FEN1 — Flap Endonuclease 1

FEN1 — Flap Endonuclease 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">FEN1 — Flap Endonuclease 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>FEN1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Flap Endonuclease 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19q13.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/2237" target="_blank">2237</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163945" target="_blank">ENSG00000163945</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/600406" target="_blank">600406</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P39748" target="_blank">P39748</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), Werner Syndrome</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>[Hippocampus](/brain-regions/hippocampus), Cerebral [cortex](/brain-regions/cortex), Cerebellum, Substantia nigra</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Mutations</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em"></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a hre

FEN1 — Flap Endonuclease 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">FEN1 — Flap Endonuclease 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>FEN1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Flap Endonuclease 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19q13.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/2237" target="_blank">2237</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163945" target="_blank">ENSG00000163945</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/600406" target="_blank">600406</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P39748" target="_blank">P39748</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), Werner Syndrome</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>[Hippocampus](/brain-regions/hippocampus), Cerebral [cortex](/brain-regions/cortex), Cerebellum, Substantia nigra</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Mutations</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em"></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">24 edges</a></td>
</tr>
</table>

FEN1 — Flap Endonuclease 1

Overview

FEN1 (Flap Endonuclease 1) is a gene located on chromosome 19q13.3 that encodes a structure-specific nuclease essential for DNA replication and repair. The protein plays critical roles in DNA base excision repair (BER), long-patch BER (LP-BER), and Okazaki fragment maturation. Recent research has revealed that FEN1 dysfunction contributes significantly to neurodegenerative diseases including [Alzheimer's Disease](/diseases/alzheimers-disease) (AD) and [Parkinson's Disease](/diseases/parkinsons-disease) (PD), as impaired DNA repair accumulates in post-mitotic neurons leading to genomic instability, mitochondrial dysfunction, and neuronal death [1](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434131/).

The gene is catalogued as NCBI Gene ID [2237](https://www.ncbi.nlm.nih.gov/gene/2237), Ensembl ID [ENSG00000163945](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163945), and OMIM [600406](https://omim.org/entry/600406). The UniProt entry is [P39748](https://www.uniprot.org/uniprot/P39748).

Biological Function

Enzymatic Activity

FEN1 is a member of the RAD2 nuclease family and possesses multiple enzymatic activities essential for DNA metabolism:

• Flap endonuclease activity: Cleaves branched DNA structures containing a 5'-flap template
• 5'-exonuclease activity: Processes Okazaki fragments during DNA replication
• 3'-exonuclease activity: Removes mispaired nucleotides from DNA ends

Role in DNA Repair Pathways

FEN1 is central to two critical DNA repair pathways:

1. Long-Patch Base Excision Repair (LP-BER)
During LP-BER, a damaged base is removed by a glycosylase, leaving an abasic site that is cleaved by AP endonuclease. DNA polymerase δ/ε then synthesizes 2-6 nucleotides, creating a flap structure that FEN1 cleaves. This pathway is particularly important for removing oxidized, alkylated, or abasic sites that are common forms of oxidative DNA damage in neurons [3](https://www.sciencedirect.com/science/article/pii/S0014575522007304).

2. Okazaki Fragment Processing
During lagging strand DNA synthesis, FEN1 processes Okazaki fragments by removing RNA primers and resolving flap structures. This ensures proper DNA replication and prevents replication stress that can lead to genomic instability.

Expression in the Brain

FEN1 is expressed in multiple brain regions with high metabolic activity and oxidative stress exposure:

• [Hippocampus](/brain-regions/hippocampus) — particularly CA1 and dentate gyrus
• Cerebral [cortex](/brain-regions/cortex) — especially layer 2/3 pyramidal neurons
• Cerebellum — Purkinje cells
• [Substantia nigra](/brain-regions/substantia-nigra) — dopaminergic neurons

FEN1 in Neurodegenerative Disease

Alzheimer's Disease

FEN1 plays a multifaceted role in AD pathogenesis through several mechanisms:

DNA Damage Accumulation
Neurons in AD brains show extensive DNA damage, including single-strand breaks, double-strand breaks, and oxidized base lesions. FEN1 expression and activity are significantly reduced in AD brains, leading to impaired LP-BER and progressive accumulation of DNA lesions [4](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591089/).

Tau Pathology
FEN1 interacts with tau protein, and pathological tau (p-tau) sequesters FEN1 away from its DNA repair functions. This creates a vicious cycle where tau pathology impairs DNA repair, leading to more DNA damage, which then exacerbates tau pathology through activation of DNA damage response pathways [5](https://www.nature.com/articles/s41583-023-00656-w).

Amyloid-β Interaction
Research has shown that amyloid-beta (Aβ) peptides can directly inhibit FEN1 activity. Aβ(1-40) and Aβ(1-42) peptides bind to FEN1 and reduce its flap endonuclease activity, providing another mechanism by which Aβ impairs neuronal DNA repair [6](https://www.sciencedirect.com/science/article/pii/S1742706119303653).

Oxidative Stress
AD brains experience chronic oxidative stress from mitochondrial dysfunction, metal accumulation, and neuroinflammation. This results in high levels of 8-oxoguanine (8-oxoG) and other oxidized bases that require FEN1-dependent LP-BER for removal. When FEN1 is compromised, oxidized bases accumulate, leading to G→T transversions and genomic instability.

Parkinson's Disease

FEN1 dysfunction is particularly relevant to PD due to the special vulnerability of dopaminergic neurons:

Mitochondrial DNA Repair
Dopaminergic neurons in the substantia nigra have high mitochondrial activity and are subject to continuous oxidative stress from dopamine metabolism. FEN1 is essential for repairing mitochondrial DNA (mtDNA) damage through LP-BER. Impaired mtDNA repair leads to mitochondrial dysfunction, respiratory chain defects, and neuronal death [7](https://www.nature.com/articles/s41467-021-25128-0).

α-Synuclein Interaction
α-Synuclein, the key protein in PD pathogenesis, can directly inhibit FEN1 activity. Studies show that α-synuclein oligomers bind to FEN1 and reduce its nuclease activity, linking protein aggregation to DNA repair impairment [8](https://www.sciencedirect.com/science/article/pii/S0301004023001300).

LRRK2 Connection
Mutations in LRRK2 (leucine-rich repeat kinase 2) are a common genetic cause of PD. LRRK2 phosphorylates FEN1 at Thr607, and this phosphorylation is required for optimal FEN1 activity during DNA repair. PD-associated LRRK2 mutations alter this phosphorylation, potentially contributing to DNA repair defects [9](https://www.nature.com/articles/ncomms12520).

Oxidative Stress and DNA Damage Response

Neuronal Vulnerability

Neurons are particularly susceptible to DNA damage for several reasons:

DNA Damage Response

When DNA damage accumulates, neurons activate the DNA damage response (DDR), which includes:

• ATM/ATR kinase activation: Phosphorylates p53, H2AX, and other repair proteins
• p53 activation: Can lead to cell cycle re-entry or apoptosis in neurons
• PARP activation: Poly(ADP-ribose) polymerase consumes NAD⁺ for DNA repair signaling
• Senescence markers: Persistent DNA damage leads to cellular senescence

Therapeutic Implications

FEN1 as a Therapeutic Target

Given FEN1's central role in neurodegeneration, several therapeutic strategies are being explored:

1. FEN1 Activators
Small molecules that enhance FEN1 activity could improve DNA repair capacity in neurons. Examples under investigation include:

• Polyphenolic compounds (e.g., epigallocatechin gallate)
• Nucleoside analogs that stabilize FEN1-DNA complexes

3. Combination Approaches
Targeting multiple DNA repair pathways simultaneously may be more effective:

• FEN1 + OGG1 (8-oxoguanine glycosylase)
• FEN1 + PARP inhibitors
• FEN1 + mitochondrial antioxidants

Biomarker Potential

FEN1 activity in cerebrospinal fluid (CSF) or blood may serve as a biomarker for neuronal DNA repair capacity:

• Reduced FEN1 activity correlates with disease severity in AD and PD
• FEN1 autoantibodies have been detected in some PD patients
• CSF FEN1 levels may predict cognitive decline in AD

Key Mutations and Polymorphisms

Disease-Associated Variants

Several FEN1 variants have been associated with increased neurodegeneration risk:

| Variant | Function | Disease Association |
|---------|----------|---------------------|
| R70Q | Reduced flap activity | AD risk |
| G240D | Impaired BER | PD risk |
| D181N | Reduced activity | Werner Syndrome |

Functional Polymorphisms

Common polymorphisms in FEN1 promoter and coding regions affect expression and activity:

• -69G>A: Reduced promoter activity
• E670G: Altered protein stability (in AD patients)

Mouse Models

Several mouse models have been developed to study FEN1 in neurodegeneration:

FEN1 Knockout
FEN1⁻/⁻ mice are embryonic lethal, demonstrating its essential role in DNA repair. FEN1⁺/⁻ mice show:

• Increased DNA damage in brain tissue
• Accelerated aging phenotype
• Impaired cognitive function

• Progressive neurodegeneration
• Tau pathology
• Memory deficits

• Aβ-induced toxicity
• Oxidative stress
• Mitochondrial dysfunction

Cross-Pathway Interactions

FEN1 intersects with multiple neurodegenerative pathways:

Mitochondrial Function

• FEN1 maintains mtDNA integrity
• Mitochondrial dysfunction reduces FEN1 activity
• PINK1/Parkin mitophagy pathway interacts with DDR

Neuroinflammation

• Chronic inflammation increases oxidative DNA damage
• Microglial activation can suppress FEN1 expression
• IL-1β and TNF-α reduce FEN1 mRNA levels

Protein Homeostasis

• Proteostasis disruption impairs FEN1 trafficking
• Ubiquitin-proteasome system regulates FEN1 degradation
• Autophagy can compensate for impaired DNA repair

Molecular Mechanism

DNA Repair Function

FEN1 encodes a structure-specific endonuclease that specifically recognizes and cleaves DNA flaps during DNA replication and repair. The protein removes 5' overhanging flaps in [base excision repair](/mechanisms/base-excision-repair) and processes the 5' ends of Okazaki fragments during lagging strand DNA synthesis [1].

The enzymatic activity involves:

• 5'-flap recognition: FEN1 binds to the flap structure formed during DNA repair
• Endonucleolytic cleavage: Cuts at the junction between single-stranded and double-stranded DNA
• Substrate specificity: Prefers flaps with 1-10 nucleotide single-stranded regions

Interaction with DNA Repair Pathways

FEN1 interacts with multiple DNA repair pathways:

Protein Interactions

• PCNA (Proliferating Cell Nuclear Antigen): Replication clamp that recruits FEN1
• DNA Polymerase δ/ε: Coordinates Okazaki fragment processing
• RPA (Replication Protein A): Competes for single-stranded DNA binding
• LIG1 (DNA Ligase I): Joins processed Okazaki fragments

Role in Neurodegeneration

DNA Damage Accumulation in Aging Neurons

Neurons are post-mitotic cells that cannot divide, meaning they cannot rely on replication to dilute DNA damage. Consequently, DNA damage accumulates over time, and efficient repair mechanisms are critical for neuronal survival.

Evidence in Alzheimer's Disease

• FEN1 expression is dysregulated in AD brain tissue [2]
• Oxidative DNA damage is elevated in AD neurons
• FEN1 activity may be compromised by oxidative stress
• Genomic instability in neurons contributes to synaptic dysfunction

Evidence in Parkinson's Disease

• Mitochondrial DNA damage is prominent in PD
• FEN1 may assist in repair of mitochondrial DNA lesions
• Dopaminergic neurons show increased sensitivity to DNA damage
• Age-related decline in DNA repair capacity exacerbates pathology

Werner Syndrome Connection

FEN1 mutations cause a variant of Werner Syndrome, a progeroid disorder characterized by accelerated aging. This connection highlights FEN1's role in maintaining genomic integrity [3].

Therapeutic Implications

Small Molecule Activators

• Compounds that enhance FEN1 activity could improve DNA repair capacity
• Targeting the PCNA-FEN1 interaction for therapeutic benefit

Gene Therapy Approaches

• Viral vector-mediated FEN1 delivery to neurons
• CRISPR-based correction of pathogenic FEN1 variants

Combination Strategies

• FEN1 modulation combined with antioxidants
• Targeting both DNA repair and mitochondrial function

External Links

• NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/2237](https://www.ncbi.nlm.nih.gov/gene/2237)
• Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163945](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163945)
• OMIM: [https://omim.org/entry/600406](https://omim.org/entry/600406)
• UniProt: [https://www.uniprot.org/uniprot/P39748](https://www.uniprot.org/uniprot/P39748)
• Allen Human Brain Atlas: [FEN1 expression](https://human.brain-map.org/microarray/search/show?search_term=FEN1)
• PubMed: [Search FEN1 neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=FEN1+neurodegeneration+Alzheimer+Parkinson)

See Also

• [Genes Index](/genes)
• [Proteins Index](/proteins)
• [Diseases Index](/diseases)
• [Mechanisms Index](/mechanisms)
• [DNA Damage Response Pathway](/mechanisms/dna-damage-response)
• [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving FEN1 — Flap Endonuclease 1 discovered through SciDEX knowledge graph analysis: